Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats

Journal of Toxicological Sciences

Volumn 23, Issue 2, 1998, Pages 113-119

  Kim, Sun Chun ^a   Hong, Jin Tae ^b   Jang, Seung Jae ^b   Kang, Won Seck ^a   Yoo, Hwan Soo ^a   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

8 oxodeoxyguanosine; Hepatic injury and hepatocarcinogenesis; Peroxisome proliferator

Indexed keywords

ALANINE AMINOTRANSFERASE; AROCLOR; ASPARTATE AMINOTRANSFERASE; BENZO[A]PYRENE; CATALASE; CLOFIBRATE; CORN OIL; DEOXYGUANOSINE DERIVATIVE; DNA; GAMMA GLUTAMYLTRANSFERASE; HYDROGEN PEROXIDE; PERFLUORODECANOIC ACID; PEROXISOME PROLIFERATOR; SODIUM AZIDE; TUMOR PROMOTER;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG CARCINOGENICITY; ELECTROCHEMICAL DETECTION; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CARCINOGENESIS; LIVER INJURY; LIVER WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TUMOR PROMOTION;

ANIMALIA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM; ZEA MAYS;

EID: 2642676076     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.23.2_113     Document Type: Article

References (30)

1. Ames, B. N. (1993): Endogenous DNA damage is related to cancer and aging. Mutat. Res., 214, 41-46.
2. Beer, R. F. and Siezer, J. W. (1953): A spectrophotometric method of measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem., 195, 133-140.
3. Bojes, H. K. and Thurman, R. G. (1996): Peroxisome proliferators activate kupffer cells in vivo. Cancer Res., 56, 1-4.
4. Borges, T., Peterson, R. E., Pitot, H. C., Robertson, L. W. and Glauert, H. P. (1993): Effect of peroxisome proliferator perfluorodecanoic acid on the promotion of 2-stage hepatocarcinogenesis in rats. Cancer Lett., 72, 111-120.
5. Bradford, M. M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. Brass, E.P. and Ruff, L. J. (1991): Effect of clofibrate treatment on hepatic prostaglandin catabolism and action. J. Pharmacol. Exp. Ther., 257, 1034-1038.
7. Capdevila, J. H., Falck, J. R. and Estabrook, R. W. (1992): Cytochrome P-450 and the arachidoniate cascade. FASEB. J., 6, 731-736.
8. Chen, H., Huang, C. Y., Wilson, M. W., Lay, L. T., Robertson, L. W., Chow, C. K. and Glauert, H. P. (1994): Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Carcinogenesis, 15, 2847-2850.
9. 3. Cancer Lett., 74, 141-145.
10. 2-generating peroxisomal fatty acly-CoA oxidase. Proc. Natl. Acad. Sci. USA 92, 7080-7084.
11. Conway, J. G., Cattly, R. C., Popp, J. A. and Butterworth, B. E. (1989): Possible mechanism in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate. Drug Metab. Rev., 21, 65-102.
12. Elliott, B. M. and Elcombe, C. R. (1987): Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisome proliferators. Carcinogenesis, 8, 1213-1218.
13. Gill, J L. (1978): Design and Analysis of Experiments in the Animal and Medical Science, vol. 1. Iowa State University Press, Ames, IA.
14. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro. Carcinogenesis, 6, 933-936.
15. Hess, R., Staubli, W. and Reiss, W. (1965): Nature of hepatomegalic effect produced by ethylchlorophenoxyisobutyrate in the rat. Nature, 208, 856-858.
16. 4 concentration in cultured hepatocytes J. Biochem. Toxicol., 10, 239-243.
17. Hosokawa, S., Tematsu, M., Aoki, T., Nakanowatari, J., Igarashi, T. and Ito, N. (1989): Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrtae, a hepatic peroxisome proliferator. Carcinogenesis, 10, 2237-2241.
18. Kasai, H., Okada, Y., Nishimura, S., Rao, M. S. and Reddy, J. K. (1989): Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49, 2603-2605.
19. Kuchino,Y., Mori, F., Kasai, H., Inoue, H., Iwai, S., Miura, K., Ohtsuka, E. and Nishimura, S. (1987): DNA templates containing 8-hydroxydeoxyguanosine are misread both at the modified base and at adjacent residues. Nature, 327, 77-79.
20. Lefevre, P. A., Tinwell, H., Galloway, S. M., Hill, R., Mackay, J. M., Elcombe, C. R., Foster, J., Randall, V., Callander, R. D. and Ashby, J. (1994): Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta™ mouse and Big Blue™ transgenic mice. Hum. Exp. Toxicol., 13, 764-775.
21. Nemali, M. R., Reddy, M. K., Usuda, N., Reddy, P.G., Comeau, L. D., Rao, M. S. and Reddy, J. K. (1989): Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol. Appl. Pharmacol., 97, 72-87.
22. Poosch, M. S. and Yamazaki, R. K. (1986): Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim.Biophys. Acta., 884, 585-593.
23. Reddy, J. K. and Laiwani, N. D. (1983): Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
24. Reddy, J. K. and Qureshi, S. A. (1979): Tumorigenicity of the hypolipidemic peroxisome proliferator ethyl-(-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br. J. Cancer, 40, 476-482.
25. Reddy, J. K., Scarpelli, D. G., Subbarao, V., and Lalwani, N. D. (1983): Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype. Toxicol. Pathol., 11, 172-178.
26. Shibutani, S., Takeshita, M. and Grollman, A.P. (1991): Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, 349, 431-434.
27. Stevenson, D. E., Kehrer, J. P., Kolaja, K. L., Walborg, E. F. and Klauing, J. E. (1993): Effect of dietary antioxidants on dieldrin-induced hepatoxicity in mice. Toxicol. Lett., 75, 177-183.
28. Tanagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. (1990): Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators: di(2-ethylhexyl)phtalate, aluminium clofibrate and simfibrate. Cancer Lett., 53, 33-38.
29. Ward, J. M., Shibata, M. A. and Devor, D. E . (1993): Emerging issues in mouse liver carcinogenesis. Toxicol. Pathol., 24, 129-137.
30. Wood, M. L., Esteve, A., Morningstar, M. L., Kuzuiemko,G. M. and Essigmann, J.M. (1992): Genetic effects of oxidative DNA damage-comparative mutagenesis of 7,8-dihydro-8-oxoguanine and 7,8-dihydro-8-oxoadenine in Escherichia coli. Nucleic Acids Res., 20, 6023-6032.